Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Bellecapital International Ltd. increased its stake in Regeneron Pharmaceuticals by 44.1%, acquiring 6,002 additional shares.

In a report released on March 2, David Risinger from Leerink Partners maintained a Hold rating on Amgen (AMGN – Research Report). The company’s ...

This was the stock's fifth consecutive day of losses.

We recently published a list of 10 Worst Performing Large Cap Stocks to Buy According to Analysts. In this article, we are ...

Above: Blake Monaghan, Owen Monaghan, Ciarán Gammell, and Isaac Rieger at a meeting about the Cole Science Fair. Submitted photo By Owen Monaghan Looking for Cole Middle School students interested in ...

Anchor Capital Advisors LLC has acquired 10,847 shares of Regeneron Pharmaceuticals, valued at $7.73 million. Other ...

At the heart of the controversy is Regeneron's alleged practice of paying credit card fees to distributors, on the condition that these fees were not passed on to Eylea customers. This arrangement, ...

Regeneron Pharmaceuticals, Inc. REGN obtained positive opinion for its pipeline candidate linvoseltamab from the European ...

The FDA has accepted the resubmission of the BLA of Ordspono for review in relapsed/refractory follicular lymphoma following previous systemic therapy.

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...